Literature DB >> 26762506

Deleting IGF-1 receptor from forebrain neurons confers neuroprotection during stroke and upregulates endocrine somatotropin.

C Daniel De Magalhaes Filho1,2, Laurent Kappeler1,2, Joëlle Dupont3, Julien Solinc1, Sonia Villapol4, Cécile Denis2,5,6, Marika Nosten-Bertrand2,5,6, Jean-Marie Billard7, Annick Blaise1,2, François Tronche2,5,6, Bruno Giros2,5,6,8, Christiane Charriaut-Marlangue4, Saba Aïd1,2, Yves Le Bouc1,2, Martin Holzenberger1,2.   

Abstract

Insulin-like growth factors control numerous processes, namely somatic growth, metabolism and stress resistance, connecting this pathway to aging and age-related diseases. Insulin-like growth factor signaling also impacts on neurogenesis, neuronal survival and structural plasticity. Recent reports demonstrated that diminished insulin-like growth factor signaling confers increased stress resistance in brain and other tissues. To better understand the role of neuronal insulin-like growth factor signaling in neuroprotection, we inactivated insulin-like growth factor type-1-receptor in forebrain neurons using conditional Cre-LoxP-mediated gene targeting. We found that brain structure and function, including memory performance, were preserved in insulin-like growth factor receptor mutants, and that certain characteristics improved, notably synaptic transmission in hippocampal neurons. To reveal stress-related roles of insulin-like growth factor signaling, we challenged the brain using a stroke-like insult. Importantly, when charged with hypoxia-ischemia, mutant brains were broadly protected from cell damage, neuroinflammation and cerebral edema. We also found that in mice with insulin-like growth factor receptor knockout specifically in forebrain neurons, a substantial systemic upregulation of growth hormone and insulin-like growth factor-I occurred, which was associated with significant somatic overgrowth. Collectively, we found strong evidence that blocking neuronal insulin-like growth factor signaling increases peripheral somatotropic tone and simultaneously protects the brain against hypoxic-ischemic injury, findings that may contribute to developing new therapeutic concepts preventing the disabling consequences of stroke.

Entities:  

Keywords:  Cerebral edema; hypoxia-ischemia; insulin-like growth factor; neuroinflammation; neuroprotection

Mesh:

Substances:

Year:  2016        PMID: 26762506      PMCID: PMC5381438          DOI: 10.1177/0271678X15626718

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  60 in total

1.  Deletion of the amyloid precursor-like protein 1 (APLP1) enhances excitatory synaptic transmission, reduces network inhibition but does not impair synaptic plasticity in the mouse dentate gyrus.

Authors:  Matej Vnencak; Mandy H Paul; Meike Hick; Stephan W Schwarzacher; Domenico Del Turco; Ulrike C Müller; Thomas Deller; Peter Jedlicka
Journal:  J Comp Neurol       Date:  2015-04-07       Impact factor: 3.215

Review 2.  The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research.

Authors:  Sang-Ho Choi; Saba Aid; Francesca Bosetti
Journal:  Trends Pharmacol Sci       Date:  2009-03-09       Impact factor: 14.819

3.  Inhibiting cell cycle progression reduces reactive astrogliosis initiated by scratch injury in vitro and by cerebral ischemia in vivo.

Authors:  Zhou Zhu; Qiang Zhang; Zhiyuan Yu; Liang Zhang; Daishi Tian; Suiqiang Zhu; Bitao Bu; Minjie Xie; Wei Wang
Journal:  Glia       Date:  2007-04-01       Impact factor: 7.452

4.  Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection.

Authors:  Laura M Frago; Covadonga Pañeda; Suzanne L Dickson; Adrian K Hewson; Jesús Argente; Julie A Chowen
Journal:  Endocrinology       Date:  2002-10       Impact factor: 4.736

5.  IGF-I and microglia/macrophage proliferation in the ischemic mouse brain.

Authors:  Steven L O'Donnell; Terra J Frederick; J Kyle Krady; Susan J Vannucci; Teresa L Wood
Journal:  Glia       Date:  2002-07       Impact factor: 7.452

Review 6.  Insulin-like growth factors in the brain and their potential clinical implications.

Authors:  Eduardo E Benarroch
Journal:  Neurology       Date:  2012-11-20       Impact factor: 9.910

7.  Glutamate excitotoxicity attenuates insulin-like growth factor-I prosurvival signaling.

Authors:  E Garcia-Galloway; C Arango; S Pons; I Torres-Aleman
Journal:  Mol Cell Neurosci       Date:  2003-12       Impact factor: 4.314

8.  Blunting type 1 insulin-like growth factor receptor expression exacerbates neuronal apoptosis following hypoxic/ischemic injury.

Authors:  Wen Liu; Joseph A D'Ercole; Ping Ye
Journal:  BMC Neurosci       Date:  2011-06-30       Impact factor: 3.288

9.  Astrocytes require insulin-like growth factor I to protect neurons against oxidative injury.

Authors:  Laura Genis; David Dávila; Silvia Fernandez; Andrea Pozo-Rodrigálvarez; Ricardo Martínez-Murillo; Ignacio Torres-Aleman
Journal:  F1000Res       Date:  2014-01-28

10.  ERK activation promotes neuronal degeneration predominantly through plasma membrane damage and independently of caspase-3.

Authors:  Srinivasa Subramaniam; Ute Zirrgiebel; Oliver von Bohlen Und Halbach; Jens Strelau; Christine Laliberté; David R Kaplan; Klaus Unsicker
Journal:  J Cell Biol       Date:  2004-05-03       Impact factor: 10.539

View more
  10 in total

1.  Circulating biomarkers in extremely preterm infants associated with ultrasound indicators of brain damage.

Authors:  Alan Leviton; Elizabeth N Allred; Raina N Fichorova; T Michael O'Shea; Lynn A Fordham; Karl K C Kuban; Olaf Dammann
Journal:  Eur J Paediatr Neurol       Date:  2018-01-31       Impact factor: 3.140

Review 2.  Is Immunomodulation a Principal Mechanism Underlying How Cell-Based Therapies Enhance Stroke Recovery?

Authors:  Nikunj Satani; Sean I Savitz
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

Review 3.  The evolving role of neuro-immune interaction in brain repair after cerebral ischemic stroke.

Authors:  Xin Wang; Wei Xuan; Zi-Yu Zhu; Yan Li; Hao Zhu; Ling Zhu; Dan-Yun Fu; Li-Qun Yang; Pei-Ying Li; Wei-Feng Yu
Journal:  CNS Neurosci Ther       Date:  2018-10-22       Impact factor: 5.243

4.  Preclinical and clinical evidence of IGF-1 as a prognostic marker and acute intervention with ischemic stroke.

Authors:  Cellas A Hayes; M Noa Valcarcel-Ares; Nicole M Ashpole
Journal:  J Cereb Blood Flow Metab       Date:  2021-03-24       Impact factor: 6.200

Review 5.  The Roles of Insulin-Like Growth Factors in Mesenchymal Stem Cell Niche.

Authors:  Amer Youssef; Doaa Aboalola; Victor K M Han
Journal:  Stem Cells Int       Date:  2017-02-16       Impact factor: 5.443

Review 6.  Insulin-Like Growth Factor 1: At the Crossroads of Brain Development and Aging.

Authors:  Sarah Wrigley; Donia Arafa; Daniela Tropea
Journal:  Front Cell Neurosci       Date:  2017-02-01       Impact factor: 5.505

7.  Young plasma ameliorates aging-related acute brain injury after intracerebral hemorrhage.

Authors:  Jun-Jie Yuan; Qin Zhang; Chang-Xiong Gong; Fa-Xiang Wang; Jia-Cheng Huang; Guo-Qiang Yang; Liang Liu; Kai Zhou; Rui Xu; Qiong Chen; Yu Zhou; Xiao-Yi Xiong; Qing-Wu Yang
Journal:  Biosci Rep       Date:  2019-05-17       Impact factor: 3.840

8.  Astrocytic Insulin-Like Growth Factor-1 Protects Neurons Against Excitotoxicity.

Authors:  Wei Chen; Bin He; Wusong Tong; Jinsong Zeng; Ping Zheng
Journal:  Front Cell Neurosci       Date:  2019-07-09       Impact factor: 5.505

9.  Transcriptomic profiling of long- and short-lived mutant mice implicates mitochondrial metabolism in ageing and shows signatures of normal ageing in progeroid mice.

Authors:  Matias Fuentealba; Daniel K Fabian; Handan Melike Dönertaş; Janet M Thornton; Linda Partridge
Journal:  Mech Ageing Dev       Date:  2021-01-14       Impact factor: 5.432

10.  IGF1R Deficiency Modulates Brain Signaling Pathways and Disturbs Mitochondria and Redox Homeostasis.

Authors:  Susana Cardoso; Icíar P López; Sergio Piñeiro-Hermida; José G Pichel; Paula I Moreira
Journal:  Biomedicines       Date:  2021-02-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.